April 6, 2018 (1:30 PM) Targeting acute leukemia by lipid-antigen specific T cells restricted for CD1 Giulia Casorati Experimental Immunology Unit, DIBIT, San Raffaele Scientific Institute Milan
Events
Ruolo della terapia con PARP inibitori nel trattamento del tumore ovarico
February 21, 2018 (1:30 PM) Ruolo della terapia con PARP inibitori nel trattamento del tumore ovarico Domenica Lorusso Chirurgia Ginecologica Fondazione IRCCS Istituto Nazionale dei Tumori Milan
Global Medicinal Chemistry & GPCR Leaders Summit
27-28 novembre London, UK Global Medicinal Chemistry & GPCR Leaders Summit Oral presentation: The systematic use of highly profiled antitumor agents in probing the sensitivity contexts of cancer cells and assessing the validity of target combinations
European Molecular Biology Laboratory Conference
5-8 novembre Heidelberg, Germany European Molecular Biology Laboratory Conference
XIX Congresso Nazionale AIOM
27-29 ottobre Roma, Italy XIX Congresso Nazionale AIOM
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
26-30 ottobre Philadelphia, Pennsylvania AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
IMI K4DD Conference 2017. Binding kinetics: time is of the essence
16-18 ottobre Berlin, Germany IMI K4DD Conference 2017. Binding kinetics: time is of the essence
XXXV Conferenza Nazionale di citometria
3-6 ottobre Paestum, Italy XXXV Conferenza Nazionale di citometria
Cancer Bio-Immunotherapy – XV NIBIT meeting
3-7 ottobre Siena, Italy Cancer Bio-Immunotherapy - XV NIBIT meeting
8th World ADC Congress
20-22 settembre San Diego, CA 8th World ADC Congress Abstract: Thienoindoles, a novel class of potent toxins for antibody drug conjugates
40 Congress of the European Society of Medical Oncology
8-12 settembre Madrid, Spain 40 Congress of the European Society of Medical Oncology
EACR AACR SIC:The challenges of optimising immuno and targeted therapies – from cancer biology to clinic
24-27 giugno Firenze, Italia EACR AACR SIC:The challenges of optimising immuno and targeted therapies - from cancer biology to clinic Abstract: 318 - NMS-P088 is a small molecule potent CSF1R kinase inhibitor with macrophages immunomodulatory activity
18th Annual Drug Discovery Summit
12-13 giugno Berlino, Germany 18th Annual Drug Discovery Summit
VII Congresso nazionale organizzato da ISMRM Italian Chapter
8-9 giugno Gaeta, Italia VII Congresso nazionale organizzato da ISMRM Italian Chapter
AACR 2017
1-5 aprile Washington, USA AACR 2017 Abstract 5163 - Characterization of NMS-E194, a selective and potent PERK inhibitor with efficacy in the KMS-11 multiple myeloma Abstract 2082 -NMS-E668, a potent and selective RET kinase inhibitor characterized by specificity...